See clearer: survey on the subjective and objective information levels as well as perception and information transfer using virtual reality headsets in patients with diabetic macular edema receiving anti-VEGF treatment.
Journal Information
Full Title: Graefes Arch Clin Exp Ophthalmol
Abbreviation: Graefes Arch Clin Exp Ophthalmol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Ophthalmology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethical approvalThis survey was classified as market research, which is exempt for an ethics approval. This survey does not include any access to identifiable private information, personal characteristics, or disease-related information of the participants. Informed consentInformed consent was obtained from all participants included in the study. Conflict of interestCE received consulting fees from Novartis Pharma GmbH, Nuremberg, Germany and Bayer Vital GmbH, Leverkusen, Germany. CE received financial support from Carl Zeiss Meditec AG, Jena, Germany. MS, PS, JD, and CM are employees of Bayer Vital GmbH. JW received consulting and speaking fees within the last 5 years from Alcon, Bayer, Novartis, Roche, Allergan. AL received consulting and speaker fees from Bayer, Novartis, Roche, Allergan, Inceptua and Zeiss.TD certifies that he has no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript. Conflict of interest CE received consulting fees from Novartis Pharma GmbH, Nuremberg, Germany and Bayer Vital GmbH, Leverkusen, Germany. CE received financial support from Carl Zeiss Meditec AG, Jena, Germany. MS, PS, JD, and CM are employees of Bayer Vital GmbH. JW received consulting and speaking fees within the last 5 years from Alcon, Bayer, Novartis, Roche, Allergan. AL received consulting and speaker fees from Bayer, Novartis, Roche, Allergan, Inceptua and Zeiss. TD certifies that he has no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript."
"Funding This study was funded by Bayer Vital GmbH."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025